SINTX Technologies's EPS (Basic) for the
three
months ended in Dec. 2024 was $-1.26.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was $-21.71.
During the past 3 years, the average EPS without NRIGrowth Rate was 88.70% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 52.80% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 22.00% per year.
During the past 13 years, SINTX Technologies's highest 3-Year average EPS without NRI Growth Rate was 91.50% per year. The lowest was -201.90% per year. And the median was 15.10% per year.
SINTX Technologies Earnings per Share (Diluted) Historical Data
The historical data trend for SINTX Technologies's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
SINTX Technologies Earnings per Share (Diluted) Chart
Competitive Comparison of SINTX Technologies's Earnings per Share (Diluted)
For the Medical Devices subindustry, SINTX Technologies's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SINTX Technologies's PE Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SINTX Technologies's PE Ratio distribution charts can be found below:
* The bar in red indicates where SINTX Technologies's PE Ratio falls into.
SINTX Technologies Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
SINTX Technologies's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2024 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-33.83
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
SINTX Technologies (NAS:SINT) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
SINTX Technologies Earnings per Share (Diluted) Related Terms
Thank you for viewing the detailed overview of SINTX Technologies's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
SINTX Technologies Inc is an advanced ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing primarily on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming an advanced ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have superb bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SINT has been successfully added to your 